Cargando…

Radiomic Features of (18)F-FDG PET in Hodgkin Lymphoma Are Predictive of Outcomes

PURPOSE: In the present study, we aimed to investigate whether the radiomic features of baseline (18)F-FDG PET can predict the prognosis of Hodgkin lymphoma (HL). METHODS: A total 65 HL patients (training cohort: n = 49; validation cohort: n = 16) were retrospectively enrolled in the present study....

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Yeye, Zhu, Yuchun, Chen, Zhiqiang, Li, Jihui, Sang, Shibiao, Deng, Shengming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8629643/ https://www.ncbi.nlm.nih.gov/pubmed/34887712 http://dx.doi.org/10.1155/2021/6347404

Ejemplares similares

Prognostic Value of Radiomic Features of (18)F-FDG PET/CT in Patients With B-Cell Lymphoma Treated With CD19/CD22 Dual-Targeted Chimeric Antigen Receptor T Cells
por: Zhou, Yeye, et al.
Publicado: (2022)

Prognostic values of baseline, interim and end-of therapy (18)F-FDG PET/CT in patients with follicular lymphoma
por: Zhou, Yeye, et al.
Publicado: (2019)

Prognostic Values of Baseline (18)F-FDG PET/CT in Patients with Peripheral T-Cell Lymphoma
por: Zhou, Yeye, et al.
Publicado: (2020)

Evaluation of PD-L1 Expression Level in Patients With Non-Small Cell Lung Cancer by (18)F-FDG PET/CT Radiomics and Clinicopathological Characteristics
por: Li, Jihui, et al.
Publicado: (2021)

The Role of (18)F-FDG PET/CT in Multiple Myeloma Staging according to IMPeTUs: Comparison of the Durie–Salmon Plus and Other Staging Systems
por: Deng, Shengming, et al.
Publicado: (2018)

Prognostic value of (18)F-FDG PET/CT radiomic model based on primary tumor in patients with non-small cell lung cancer: A large single-center cohort study
por: Li, Jihui, et al.
Publicado: (2022)

Analysis of Positive Results of (18)F-FDG PET/CT Imaging after Hematopoietic Stem Cell Transplantation in Lymphoma
por: Dai, Na, et al.
Publicado: (2023)

Assessment of androgen receptor expression in breast cancer patients using 18 F-FDG PET/CT radiomics and clinicopathological characteristics
por: Jia, Tongtong, et al.
Publicado: (2023)

Identification of multiple cardiac metastases from nonsmall-cell lung cancer by (18)F-FDG PET/CT: A case report
por: Deng, Shengming, et al.
Publicado: (2018)

Imaging Characteristics and Prognostic Value of Isolated Pulmonary Metastasis from Colorectal Cancer Demonstrated with(18)F-FDG PET/CT
por: Yu, Yu, et al.
Publicado: (2022)

Case report of primary renal pelvis squamous cell carcinoma coexisting with long-standing calculi in left kidney on (18)F-FDG PET/CT
por: Deng, Shengming, et al.
Publicado: (2017)

Radiomic signatures based on pretreatment 18F-FDG PET/CT, combined with clinicopathological characteristics, as early prognostic biomarkers among patients with invasive breast cancer
por: Jia, Tongtong, et al.
Publicado: (2023)

The value of (18)F-FDG PET/CT in the prediction of clinical outcomes of patients with acute leukemia treated with allogeneic hematopoietic stem cell transplantation
por: Zhao, Zixuan, et al.
Publicado: (2020)

Baseline (18)F-FDG PET/CT Radiomics in Classical Hodgkin’s Lymphoma: The Predictive Role of the Largest and the Hottest Lesions
por: Triumbari, Elizabeth Katherine Anna, et al.
Publicado: (2023)

A Rare Case of Thymic Rosai-Dorfman Disease Mimicking Malignancy on (18)F-FDG PET/CT
por: Jia, Tongtong, et al.
Publicado: (2022)

Prognostic model using (18)F-FDG PET radiomics predicts progression-free survival in relapsed/refractory Hodgkin lymphoma
por: Driessen, Julia, et al.
Publicado: (2023)

CD19/CD22 chimeric antigen receptor (CAR) T-cell cocktail therapy following autologous transplantation in patients with relapsed/refractory diffuse large B-cell lymphoma on (18)F-FDG PET/CT: a case description
por: Zhou, Yeye, et al.
Publicado: (2023)

Prognostic Value of 2-Deoxy-2-[(18)F]fluoro-D-glucose Positron Emission Tomography/Computed Tomography after Autologous Hematopoietic Stem Cell Transplantation in Lymphoma Using Deauville Scores
por: Dai, Na, et al.
Publicado: (2021)

[(18)F]FDG-PET/CT in Hodgkin Lymphoma: Current Usefulness and Perspectives
por: Kanoun, Salim, et al.
Publicado: (2018)

Assessing radiomic feature robustness to interpolation in (18)F-FDG PET imaging
por: Whybra, Philip, et al.
Publicado: (2019)

Ability of (18)F-FDG PET/CT Radiomic Features to Distinguish Breast Carcinoma from Breast Lymphoma
por: Ou, Xuejin, et al.
Publicado: (2019)

(18)F-FDG PET baseline radiomics features improve the prediction of treatment outcome in diffuse large B-cell lymphoma
por: Eertink, Jakoba J., et al.
Publicado: (2021)

Quantitative accuracy of radiomic features of low-dose (18)F-FDG PET imaging
por: Gao, Xin, et al.
Publicado: (2020)

(18)F-FDG-PET-based radiomics features to distinguish primary central nervous system lymphoma from glioblastoma
por: Kong, Ziren, et al.
Publicado: (2019)

Prognostic Value of Baseline Radiomic Features of (18)F-FDG PET in Patients with Diffuse Large B-Cell Lymphoma
por: Lue, Kun-Han, et al.
Publicado: (2020)

Combination of FDG PET/CT Radiomics and Clinical Parameters for Outcome Prediction in Patients with Hodgkin’s Lymphoma
por: Ortega, Claudia, et al.
Publicado: (2023)

Baseline (18)F-FDG PET/CT radiomics for prognosis prediction in diffuse large B cell lymphoma
por: Jing, Fenglian, et al.
Publicado: (2023)

The role of FDG-PET in Hodgkin lymphoma
por: Subocz, Edyta, et al.
Publicado: (2017)

Pediatric Hodgkin Lymphoma: Predictive value of interim (18)F-FDG PET/CT in therapy response assessment
por: Ferrari, Cristina, et al.
Publicado: (2017)

(18)F-FDG PET/CT Findings of Non-Hodgkin Lymphoma Involving the Whole Genitourinary System
por: Oral, Aylin, et al.
Publicado: (2018)

Predicting EGFR mutation subtypes in lung adenocarcinoma using (18)F-FDG PET/CT radiomic features
por: Liu, Qiufang, et al.
Publicado: (2020)

FDG PET for therapy monitoring in Hodgkin and non-Hodgkin lymphomas
por: Barrington, Sally F., et al.
Publicado: (2017)

Prospective Evaluation of Different Methods for Volumetric Analysis on [(18)F]FDG PET/CT in Pediatric Hodgkin Lymphoma
por: Lopci, Egesta, et al.
Publicado: (2022)

The Influence of the Exclusion of Central Necrosis on [(18)F]FDG PET Radiomic Analysis
por: Noortman, Wyanne A., et al.
Publicado: (2021)

Radiomics–clinical nomogram based on pretreatment 18F-FDG PET-CT radiomics features for individualized prediction of local failure in nasopharyngeal carcinoma
por: Ding, Jianming, et al.
Publicado: (2023)

Influence of age on radiomic features in (18)F-FDG PET in normal breast tissue and in breast cancer tumors
por: Boughdad, Sarah, et al.
Publicado: (2018)

A Case of Extranodal Testicular Involvement in Non-Hodgkin’s Lymphoma Detected through (18)F-FDG PET-CT
por: Coulier, B., et al.
Publicado: (2015)

Quantitative classification and radiomics of [(18)F]FDG-PET/CT in indeterminate thyroid nodules
por: de Koster, Elizabeth J., et al.
Publicado: (2022)

[(18)F]FDG-PET/CT radiomics for the identification of genetic clusters in pheochromocytomas and paragangliomas
por: Noortman, Wyanne A., et al.
Publicado: (2022)

Use of (18)F FDG PET and the short temporal response of Hodgkin's disease to RIT
por: Nowosinska, Ewa, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_4jhbg2tf2hveu5m4d9fqqd030m